Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
11-31
Author(s):
W. Jelkmann
Transcription Factors as Potential Targets for Therapeutic Drugs
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
57-61
Author(s):
David S. Latchman
Toward The Rational Design of Cell Fate Modifiers Notch Signaling as a Target for Novel Biopharmaceuticals
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
83-106
Author(s):
A. Zlobin, M. Jang and L. Miele
Recent Developments in Receptor-Selective Retinoids
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
919-931
Author(s):
Sunil Nagpal and Roshantha A.S. Chandraratna
Mechanisms for the Selective Actions of Vitamin D Analogues
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
701-716
Author(s):
Alex J. Brown
Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
717-732
Author(s):
Gert-Jan C.M. van den Bemd, Huibert A.P. Pols and Johannes P.T.M. van Leeuwen
Therapeutic Applications for Ligands of Retinoid Receptors
Journal:
Current Pharmaceutical Design
Volume:
6
Page:
25-58
Author(s):
Scott M. Thacher, Jayasree Vasudevan and Roshantha A.S. Chandraratna
Withdrawal Notice: Mucoadhesive Microspheres: An Emerging Trends in Therapy of Diabetes Mellitus
Journal:
Current Diabetes Reviews
Volume:
16
Page:
1-1
Author(s):
Deepika Singh* and Deepak Choudhary
Withdrawal Notice: Drug Repurposing for Prospective Anti-Cancer Agents Along with the Clinical Status of the Repurposed Drug
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
20
Page:
1-1
Author(s):
Anjali S. Sabale, Unnati M. Patel, Ankita A. Gorhe, Vinayak R. Bodhankar, Mahesh N. Shinde, Gaurav A. Sonawane, Hitesh S. Raotole, Rohit Y. Pande and Abhijeet D. Kulkarni*
Withdrawal Notice: Comparison of Pharmaceutical Effect of Alemtuzumab and Natalizumab and Their Side Effects in Treatment of Various Stages of Multiple Sclerosis Patients
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
20
Page:
1-1
Author(s):
Mostafa Mohammadi*